radiopharmaceuticals

Biotech

Belgian bio Precirix nabs $88M for radiopharmaceuticals in HER2

Precirix will use the fresh funds to bankroll a phase 1/2 study of its first radiopharmaceutical in HER2-positive cancers and hire staff in the U.S.
Kyle LaHucik Mar 16, 2022 3:00am

Galera shares rise over 100% as phase 3 flop deemed an error

Dec 14, 2021 3:30pm

Novartis tags Molecular Partners for $580M radioligand deal

Dec 14, 2021 10:34am

Ex-Ra Pharma execs snag $75M for Curie's radiopharmaceuticals

Dec 1, 2021 9:45am

Galera shares slide as radiotherapy complication drug fails

Oct 19, 2021 11:53am

Crinetics creates Radionetics with $30M for 10 cancer candidates

Oct 18, 2021 4:14pm